RBC Capital Reiterates Outperform on CVS Health, Maintains $91 Price Target
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Ben Hendrix has reiterated an Outperform rating on CVS Health (NYSE:CVS) and maintained a price target of $91.
August 18, 2023 | 2:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has reiterated an Outperform rating on CVS Health and maintained a price target of $91.
The reaffirmation of the Outperform rating and the maintenance of the $91 price target by RBC Capital indicates a positive outlook for CVS Health. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100